Researchers from the Weizmann Institute of Science and Steba Biotech have reportedly developed a light-sensitive drug derived from deep-sea bacteria that has been shown to kill cancer cells in low-risk prostate cancer patients without affecting healthy tissue. The team’s work was published in Lancet Oncology. Vascular-targeted photodynamic therapy, VTP, utilizes a drug called WST11 which was […]
Weizmann Institute of Science
MedGadget’s MedTech Monday: Sniff control for a wheelchair
Sniff control for a wheelchair: Researchers at the Weizmann Institute in Israel developed a nose-sniff-controlled wheelchair that a new study in the Proceedings of The National Academy of Sciences demonstrates to be practical for use by the severely disabled. Because sniffing often remains as the sole bodily mechanism with any kind of precise control in many completely paralyzed, or ‘locked-in,’ patients, it can also serve as a good communication link with the rest of the world.
